Silence Therapeutics PLCSilence Therapeutics PLC - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you work at Silence Therapeutics PLC and you wish to use your ESG rating, please get in touch. The dashboard contains a questions and answers section on Silence Therapeutics PLC. This assessment of Silence Therapeutics PLC uses intelligence from across the internet and also from available disclosures by Silence Therapeutics PLC.

Silence Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 1.6, social score of 6.4 and governance score of 5.3.

SDG Transparency Score for Silence Therapeutics PLC 
Low
0 - 3

4.4

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Silence Therapeutics PLC 
1.6

Environmental

6.4

Social

5.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1252Wntresearch AB
4.5
High
1252Verano Holdings Corp
4.5
High
1284Silence Therapeutics PLC
4.4
High
1284Adinath Biolabs Ltd
4.4
High
1284Aligos Therapeutics Inc
4.4
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Silence Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Silence Therapeutics PLC report the average age of the workforce?

LockedSign up for free to unlock

Does Silence Therapeutics PLC reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose cybersecurity risks?

LockedSign up for free to unlock

Does Silence Therapeutics PLC offer flexible work?

LockedSign up for free to unlock

Does Silence Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Silence Therapeutics PLC conduct supply chain audits?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Silence Therapeutics PLC conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose water use targets?

LockedSign up for free to unlock

Does Silence Therapeutics PLC have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Silence Therapeutics PLC have a product recall in the last two years?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose incidents of discrimination?

LockedSign up for free to unlock

Does Silence Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Silence Therapeutics PLC issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose parental leave metrics?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Silence Therapeutics PLC support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Silence Therapeutics PLC reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Silence Therapeutics PLC involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose its waste policy?

LockedSign up for free to unlock

Does Silence Therapeutics PLC report according to TCFD requirements?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose energy use targets?

LockedSign up for free to unlock

Does Silence Therapeutics PLC disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Silence Therapeutics PLC have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Silence Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver. It designs short interfering RNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell. The company is developing various product candidates, including SLN360, which is Phase I clinical trials for the treatment of cardiovascular disease with high lipoprotein; SLN124 that is in Phase I clinical trials for the treatment of non-transfusion dependent thalassemia, and Phase I clinical trials for the treatment of myelodysplastic syndrome; and SLN124 for the treatment of polycythemia vera. It has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize small interfering RNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and Mallinckrodt Pharma IP Trading DAC to develop and commercialize RNAi drug targets designed to silence the complement cascade in complement-mediated disorders. The company also has a collaboration with Hansoh Pharmaceutical Group Company Limited to develop siRNAs for three undisclosed targets leveraging Silence's mRNAi GOLD platform. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom.

Sorry!

Failed to process!